Comparison of the characteristics of patients treated with and without Propofol
Phase 3
- Conditions
- Patients treated with and without Propofol in the intensive care unit..
- Registration Number
- IRCT20150107020592N19
- Lead Sponsor
- The Edjucational , Research and Treatment center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Patients need a sedative in the intensive care unit
Exclusion Criteria
Patients with propofol sensivity
Patients with certain underlying conditions
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the effects and risks of using propofol. Timepoint: After using propofol. Method of measurement: The checklist includes demographic features and variables such as cardiac output, hypotension, hyperlipidemia, and sepsis.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: Before and after the intervention. Method of measurement: Barometer.;Cardiac Output. Timepoint: Before and after intervention. Method of measurement: monitoring.